Xin Y. Lee
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial.
Journal: Neurology and therapy
Published: November 13, 2025
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed.
Journal: European journal of neurology
Published: September 26, 2025
Unconscious cognition without post hoc selection artifacts: From selective analysis to functional dissociations.
Journal: Behavior research methods
Published: September 12, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial.
Journal: European journal of neurology
Published: July 02, 2025
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed.
Journal: Advances in therapy
Published: June 11, 2025
Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: post hoc analysis of the DELIVER trial.
Journal: Journal of patient-reported outcomes
Published: February 08, 2024
Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab.
Journal: The journal of headache and pain
Published: January 30, 2024
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.
Journal: The journal of headache and pain
Published: December 22, 2023
Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention.
Journal: Journal of medical economics
Published: August 18, 2023
Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS).
Journal: Neurology and therapy
Published: July 05, 2023
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 31, 2023
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration.
Journal: Journal of comparative effectiveness research
Published: May 24, 2023
Last Updated: 09/26/2026